Stocks and Investing Stocks and Investing
Tue, June 14, 2011

BCRX, IRIS, MLR, BIOS, SSD, COCO Expected to Trade Up After Bullish Patterns Develop


Published on 2011-06-14 06:11:16 - WOPRAI
  Print publication without navigation


June 14, 2011 / M2 PRESSWIRE / BUYINS.NET / http://www.squeezetrigger.com is monitoring top technical trading patterns and these stocks are the most likely to trade Up in the coming weeks. BIOCRYST PHARMACEUTICALS INC (NASDAQ:BCRX), IRIS INTERNATIONAL INC (NASDAQ:IRIS), MILLER INDUSTRIES INC/TENN (NYSE:MLR), BIOSCRIP INC (NASDAQ:BIOS), SIMPSON MANUFACTURING CO INC (NYSE:SSD), CORINTHIAN COLLEGES INC (NASDAQ:COCO) are all expected to go Up as Bullish signals have been generated by top technical trading patterns. We monitor these patterns: Support Break, Support Reversal, Breakaway Gap, Measured Gap, Exhaustion Gap, Resistance Break, Resistance Reversal, Saucer Reversal, Volume Climax, Volume Trend, Fibonacci Reversal, Consolidation Breaks, Trend Line Break,Trend Line Reversal, Candles, Golden Crosses, Death Crosses and more. The chart below displays the stocks expected to go Up along with pattern, strategy and strength ratings.

     Symbol     Company                             Strategy                            Pattern Name            Strength  
     BCRX       BIOCRYST PHARMACEUTICALS INC        Breakout (Stocks) DO                Trend Line Break(2)     5         
     IRIS       IRIS INTERNATIONAL INC              Breakout (Stocks) DO                Breakaway Gap           1         
     MLR        MILLER INDUSTRIES INC/TENN          Trending (Stocks) DO                Trend Line Reversal(5+)     3         
     BIOS       BIOSCRIP INC                        Breakout (Stocks) DO                Resistance Reversal(1)     1         
     SSD        SIMPSON MANUFACTURING CO INC        Reversal (Stocks) DWC               Trend Line Break(5+)     5         
     COCO       CORINTHIAN COLLEGES INC             Trending (Stocks) DO                Trend Line Break(3)     5         
Chart Pattern Recognition is based on a 20-year patterns database. This database is used to determine pattern strength for patterns as they appear. There is no optimization and the pattern signals never change. For each pattern variation, we record accuracy and profitability statistics in a patterns database. From this information, we are able to define strength ratings from 1 to 5. The '1' rating shows ALL patterns while a '5' rating shows the best patterns according to profitability. Each pattern has its own strength rating factors. The result is an automatic ranking system that allows us to only show the BEST patterns. You can see that, at Strength 5, virtually all the patterns are profitable. The pattern strength rating system separates the most profitable patterns. The specific technology used to make these predictions is available for a low monthly fee at: http://www.squeezetrigger.com/services/sw/ot.php

BIOCRYST PHARMACEUTICALS INC (NASDAQ:BCRX) - BioCryst Pharmaceuticals, Inc. designs, optimizes, and develops small-molecule pharmaceuticals that block key enzymes involved in infectious diseases, cancer, and inflammatory diseases. It uses structure-based drug design, which incorporates multiple scientific disciplines, including biology, crystallography, medicinal chemistry, and computer modeling to develop new therapeutic candidates. The company has progressed two compounds into late-stage pivotal clinical trials comprising Peramivir, an anti-viral for influenza; and Forodesine, a purine nucleoside phosphorylase (PNP) inhibitor forcutaneous T-cell lymphoma (CTCL). Peramivir is being developed under a contract from the Biomedical Advanced Research and Development Authority (BARDA) within the United States Department of Health and Human Services (HHS). Forodesine has been granted Orphan Drug status by the FDA for three indications, including T-cell non-Hodgkin's lymphoma, including CTCL; CLL and related leukemias, such as T-cell prolymphocytic leukemia, adult T-cell leukemia, and hairy cell leukemia; and for the treatment of B-ALL. BioCryst Pharmaceuticals is also testing BCX-4208, a second generation PNP inhibitor, which is in a Phase II study for the treatment of gout. The company utilizes crystallography and structure-based drug design to discover additional compounds and to progress others through pre-clinical and early development to address the unmet medical needs of patients and physicians. It has strategic alliances with the U.S. Department of Health and Human Services; Shionogi & Co., Ltd.; Green Cross Corporation; and Mundipharma International Holdings Limited. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is based in Durham, North Carolina.

IRIS INTERNATIONAL INC (NASDAQ:IRIS) - IRIS International, Inc. manufactures in vitro diagnostic (IVD) products for urinalysis and body fluids. The companys IVD segment offers iQ analyzer, an automated urine microscopy and body fluids analyzer; iQ Body Fluids Module; Optional iWare Software; iChem VELOCITY and iRICELL, an automated urine chemistry analyzer; 3GEMS Urinalysis and Body Fluids; and 3GEMS Hematology, a blood count analyzer. This segment also provides consumables for microscopy systems, test strips, calibrators, controls, and urine chemistry analyzers. Its Sample Processing segment offers benchtop centrifuges, small instruments, and supplies used for applications in coagulation, cytology, hematology, urinalysis, and DNA processing. This segment provides Express centrifuge line for clinical diagnostic market; ThermoBrite, a DNA workstation for FISH procedures; Cytofuge 2, a centrifuge for layer cell preparation; Cytofuge 12, a 12 placement centrifuge used for thin layer cell preparation; IDEXX Drive and IDEXX whole blood separator for use in IDEXX chemistry analyzers; and OvaTube, an ova and parasite testing for veterinarian market. The companys Personalized Medicine segment offers oncology and molecular diagnostics services. This segments products include Arista Molecular Tests for the diagnosis and prognostication of pathologic entities; Flow cytometry, a cell analysis platform; FISH for the detection of DNA on chromosomes; NADiA ProsVue used in prognostication of patients; NADiA HIV to monitor HIV viral load; and NADiA CECs for the detection of circulating epithelial cells. It serves medical institutions, commercial laboratories, clinics, doctors offices, veterinary laboratories, and research facilities. IRIS International sells its products through a direct sales and service force in the United States, as well as through distributors internationally. The company was founded in 1979 and is headquartered in Chatsworth, California.

MILLER INDUSTRIES INC/TENN (NYSE:MLR) - Miller Industries, Inc. engages in the manufacture and sale of vehicle towing and recovery equipment in North America and internationally. It offers wreckers, including conventional tow trucks to large recovery vehicles used to recover and tow disabled vehicles and other equipment; car carriers, specialized flat-bed vehicles with hydraulic tilt mechanisms used to transport new or disabled vehicles and other equipment; and transport trailers, specialized auto transport trailers with upper and lower decks and hydraulic ramps used for moving multiple vehicles for auto auctions, car dealerships, leasing companies, and other similar applications. The company offers its products under the Century, Challenger, Holmes, Champion, Eagle, Titan, Jige, Boniface, Vulcan, and Chevron brand names. Miller Industries sells its products through sales representatives and independent distributors primarily in the United States, Canada, Mexico, Europe, the Pacific Rim, the Middle East, South America, and Africa. The company was founded in 1994 and is based in Ooltewah, Tennessee.

BIOSCRIP INC (NASDAQ:BIOS) - BioScrip, Inc., a specialty pharmaceutical healthcare organization, provides medications and management solutions for chronic and other healthcare conditions in the United States. It operates through two segments, Specialty Pharmacy Services and Traditional Pharmacy Services. The Specialty Pharmacy Services segment provides specialty pharmacy distribution and therapy management services. Specialty pharmacy services distribution occurs locally through community pharmacies, centrally through mail order facilities, and through its infusion pharmacies for patients requiring infused medications in the home or infused at various sites, including the companys ambulatory infusion sites. As of December 31, 2009, it owned and operated 43 specialty pharmacies comprising community, mail order, and infusion pharmacies. This segment primarily focuses on serving patient populations with chronic health conditions, including psoriasis; growth hormones, thyroid cancer; sickle cell anemia/thalassemia, myelodysplastic syndromes, and bleeding disorders/hemophilia; multiple sclerosis and neuropathies; in office infusions and oral oncolytics; rheumatoid arthritis, osteoarthritis, and osteoporosis; solid organ and bone marrow transplant; and HIV/AIDS, hepatitis, and respiratory syncytial virus. The Traditional Pharmacy Services segment consists of traditional mail service pharmacy fulfillment, prescription discount card programs, and pharmacy benefit management services. This segment offers clinical, formulary, benefit design, drug usage evaluation, pharmacy data, and mail order pharmacy dispensing services; and discount prescription card programs. The company distributes pharmaceuticals, and provides clinically focused case and disease management programs to healthcare payors, including managed care organizations, government-funded and/or operated programs, third party administrators, and self-funded employer groups. BioScrip, Inc. was founded in 1993 and is based in Elmsford, New York.

SIMPSON MANUFACTURING CO INC (NYSE:SSD) - Simpson Manufacturing Co., Inc., through its subsidiaries, engages in the design, engineering, manufacture, and sale of building products. The company offers wood-to-wood, wood-to-concrete, and wood-to-masonry connectors; screw fastening systems and collated screws; stainless steel fasteners; and pre-fabricated shear walls. It also provides adhesives, mechanical anchors, carbide drill bits, and powder actuated tools for concrete, masonry, and steel markets. Simpson Manufacturing Co. markets its products for the residential construction, light industrial and commercial construction, remodeling, and do-it-yourself markets in the United States, Europe, Canada, Asia, Australia, New Zealand, Mexico, and other countries in central and South America and the Middle East. It distributes its products to home centers through wholesale distributors, contractors and dealers, and original equipment manufacturers. The company was founded in 1956 and is based in Pleasanton, California.

CORINTHIAN COLLEGES INC (NASDAQ:COCO) - Corinthian Colleges, Inc. operates as a post-secondary career education company in the United States and Canada. The company offers various diploma programs, as well as associates, bachelors, and masters degrees. Its diploma curricula includes medical assisting, medical insurance billing and coding, massage therapy, dental assisting, pharmacy technician, medical administrative assisting, automotive and diesel technology, surgical technology, plumbing, electrical, nursing, electronics, and computer technology programs, as well as heating, ventilating, and air conditioning. The companys degree curriculum comprises business administration, criminal justice, medical assisting, registered nursing, accounting, paralegal, marketing, computer information technology, legal assisting, hospitality management, court reporting, applied service management, and film and video programs. It also offers online degrees primarily in business administration and criminal justice. In addition, the company provides online learning to the students pursuing education through online. As of December 31, 2010, the company operated 105 schools in 25 states; and 17 colleges in the province of Ontario, Canada under the Everest, WyoTech, and Heald brand names. Corinthian Colleges, Inc. was founded in 1995 and is based in Santa Ana, California.

About BUYINS.NET

BUYINS.NET, www.buyins.net , monitors trading in all US stocks in real time and maintains massive databases of short sale and naked short sale time and sales data, short squeeze SqueezeTrigger prices, market maker price movements, shareholder data, statistical data on earnings, sector correlation, seasonality, hedge fund trading strategies, comparable valuations. Reports include:

REGULATORY & COMPLIANCE NEWS

Friction Factor -- market maker surveillance system tracking Level II market makers in all stocks to determine Price Friction and compliance with new "Fair Market Making Requirements"

RegSHO Naked Shorts -- tracks EVERY failure to deliver in all US stocks and tracks all Threshold Security Lists daily for which stocks have naked shorts that are not in compliance with Regulation SHO

INVESTMENTS & TRADING

SqueezeTrigger -- 29 billion cell database tracks EVERY short sale (not just total short interest) in all US stocks and calculates volume weighted price that a short squeeze will begin in each stock.

Earnings Edge -- predicts probability, price move and length of move before and after all US stock earnings reports.

Seasonality -- predicts probability, price move and length of move based on exact time of year for all US stocks.

Group Trader -- tracks sector rotation and stock correlation to its sector and predicts future moves in ALL sectors and industry groups.

Pattern Scan -- automates tracking of every technical pattern and predicts time and size of move in all stocks.

GATS (Global Automated Trading System) -- tracks all known trading strategies and qualifies and quantifies which are working best in real time.

DISCLAIMER:

BUYINS.NET is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. BUYINS.NET has not been compensated by any of the above mentioned companies. Past performance is not indicative of future results. Please visit our web site, www.buyins.net , for complete risks and disclosures.

Contact:

BUYINS.NET Thomas Ronk 800-715-9999 tom@buyins.net www.buyins.net

Contributing Sources